News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
632,418 Results
Type
Article (47460)
Company Profile (195)
Press Release (584763)
Multimedia
Podcasts (105)
Webinars (13)
Section
Business (179510)
Career Advice (2539)
Deals (32557)
Drug Delivery (124)
Drug Development (77858)
Employer Resources (159)
FDA (16342)
Job Trends (13613)
News (314894)
Policy (32565)
Tag
Academia (2432)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (84)
Alliances (43911)
ALS (92)
Alzheimer's disease (1472)
Antibody-drug conjugate (ADC) (144)
Approvals (16303)
Artificial intelligence (268)
Autoimmune disease (27)
Automation (12)
Bankruptcy (329)
Best Places to Work (10237)
BIOSECURE Act (22)
Biosimilars (118)
Biotechnology (101)
Bladder cancer (82)
Brain cancer (29)
Breast cancer (279)
Cancer (2250)
Cardiovascular disease (191)
Career advice (2125)
Career pathing (34)
CAR-T (149)
Cell therapy (435)
Cervical cancer (20)
Clinical research (63347)
Collaboration (798)
Company closure (1)
Compensation (544)
Complete response letters (29)
COVID-19 (2684)
CRISPR (43)
C-suite (238)
Cystic fibrosis (97)
Data (2125)
Decentralized trials (2)
Denatured (24)
Depression (53)
Diabetes (278)
Diagnostics (5744)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (42)
Drug discovery (117)
Drug pricing (125)
Drug shortages (32)
Duchenne muscular dystrophy (97)
Earnings (74448)
Editorial (45)
Employer branding (20)
Employer resources (142)
Events (101941)
Executive appointments (701)
FDA (17607)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (691)
Gene editing (106)
Generative AI (23)
Gene therapy (326)
GLP-1 (817)
Government (4226)
Grass and pollen (6)
Guidances (64)
Healthcare (16203)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (142)
Indications (28)
Infectious disease (2833)
Inflammatory bowel disease (138)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (93)
Interviews (465)
IPO (15496)
IRA (49)
Job creations (3785)
Job search strategy (1774)
Kidney cancer (11)
Labor market (33)
Layoffs (521)
Leadership (24)
Legal (7878)
Liver cancer (75)
Lung cancer (325)
Lymphoma (155)
Machine learning (7)
Management (54)
Manufacturing (320)
MASH (73)
Medical device (11810)
Medtech (11814)
Mergers & acquisitions (17608)
Metabolic disorders (760)
Multiple sclerosis (81)
NASH (23)
Neurodegenerative disease (106)
Neuropsychiatric disorders (34)
Neuroscience (2040)
NextGen: Class of 2025 (5471)
Non-profit (3511)
Now hiring (23)
Obesity (419)
Opinion (247)
Ovarian cancer (69)
Pain (92)
Pancreatic cancer (79)
Parkinson's disease (155)
Partnered (18)
Patents (238)
Patient recruitment (105)
Peanut (46)
People (51992)
Pharmaceutical (81)
Pharmacy benefit managers (21)
Phase I (19003)
Phase II (27657)
Phase III (21804)
Pipeline (1222)
Policy (170)
Postmarket research (2625)
Preclinical (7961)
Press Release (52)
Prostate cancer (111)
Psychedelics (37)
Radiopharmaceuticals (239)
Rare diseases (406)
Real estate (5311)
Recruiting (64)
Regulatory (22688)
Reports (34)
Research institute (2222)
Resumes & cover letters (417)
Rett syndrome (4)
RNA editing (4)
RSV (47)
Schizophrenia (80)
Series A (127)
Series B (80)
Service/supplier (11)
Sickle cell disease (56)
Special edition (16)
Spinal muscular atrophy (151)
Sponsored (33)
Startups (3286)
State (2)
Stomach cancer (16)
Supply chain (73)
Tariffs (46)
The Weekly (79)
Vaccines (780)
Venture capitalists (43)
Weight loss (301)
Women's health (33)
Worklife (20)
Date
Today (50)
Last 7 days (885)
Last 30 days (2565)
Last 365 days (31854)
2025 (10730)
2024 (33955)
2023 (38220)
2022 (48774)
2021 (52657)
2020 (49898)
2019 (40691)
2018 (30985)
2017 (31222)
2016 (30256)
2015 (34451)
2014 (28152)
2013 (23388)
2012 (25089)
2011 (25764)
2010 (23584)
Location
Africa (767)
Alabama (49)
Alaska (7)
Arizona (196)
Arkansas (11)
Asia (38088)
Australia (6270)
California (5904)
Canada (1791)
China (494)
Colorado (259)
Connecticut (287)
Delaware (151)
Europe (87221)
Florida (886)
Georgia (190)
Hawaii (1)
Idaho (41)
Illinois (491)
India (27)
Indiana (274)
Iowa (11)
Japan (160)
Kansas (91)
Kentucky (22)
Louisiana (7)
Maine (63)
Maryland (881)
Massachusetts (4475)
Michigan (196)
Minnesota (351)
Mississippi (1)
Missouri (73)
Montana (17)
Nebraska (22)
Nevada (57)
New Hampshire (56)
New Jersey (1687)
New Mexico (17)
New York (1646)
North Carolina (984)
North Dakota (6)
Northern California (2597)
Ohio (171)
Oklahoma (10)
Oregon (31)
Pennsylvania (1291)
Puerto Rico (10)
Rhode Island (22)
South America (1145)
South Carolina (21)
South Dakota (1)
Southern California (2229)
Tennessee (92)
Texas (839)
United States (22143)
Utah (165)
Virginia (141)
Washington D.C. (63)
Washington State (534)
West Virginia (3)
Wisconsin (58)
632,418 Results for "cosmo pharmaceuticals s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care
Medtronic plc, a global leader in healthcare technology, announces that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals.
December 11, 2023
·
7 min read
Business
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
Cosmos Health Inc. announced the successful acquisition of the distribution network owned by Pharmatrade S.A., an established pharmaceutical wholesale company operating in Greece.
February 29, 2024
·
4 min read
Press Releases
Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait
January 24, 2025
·
4 min read
Press Releases
Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries
January 13, 2025
·
6 min read
Press Releases
Acadia Pharmaceuticals Set to Join S&P SmallCap 600
December 31, 2024
·
1 min read
Press Releases
Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements
August 23, 2024
·
4 min read
Deals
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
Cosmos Health Inc. (“Cosmos Health” or the “Company’’) (NASDAQ:COSM) announced today that it has entered into a definitive agreement, subject to customary closing conditions, with a related party to acquire the license and rights for “DIABIT-IS X”, a drug used in the treatment of type-2 diabetes.
December 20, 2023
·
4 min read
Deals
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
Cosmos Health Inc. provided a business update highlighting the expected revenue growth resulting from the various companies and assets it acquired within 2023, as well as a forecast for revenue, gross profit, and EBITDA in the upcoming year, exclusively attributed to these acquisitions.
December 27, 2023
·
6 min read
Press Releases
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
April 29, 2025
·
3 min read
Deals
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
Cosmos Health Inc. announced an agreement with Cloudpharm PC to acquire the rights arising from the patent filed with the World Intellectual Property Organization, under reference code PCT/EP2023/071865.
December 7, 2023
·
4 min read
1 of 63,242
Next
